Novavax (NVAX) EBT Growth (5y) (2015 - 2026)
Novavax (NVAX) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.81% |
| Dec 31, 2025 | 16.01% |
| Sep 30, 2025 | -0.57% |
| Jun 30, 2025 | 52.07% |
| Mar 31, 2025 | 85.73% |
| Dec 31, 2024 | -19.33% |
| Sep 30, 2024 | -46.63% |
| Jun 30, 2024 | 43.84% |
| Mar 31, 2024 | -27.45% |
| Dec 31, 2023 | -29.83% |
| Sep 30, 2023 | -24.16% |
| Jun 30, 2023 | 26.95% |
| Mar 31, 2023 | -42.93% |
| Dec 31, 2022 | -30.36% |
| Sep 30, 2022 | -30.08% |
| Jun 30, 2022 | -62.84% |
| Mar 31, 2022 | 45.12% |
| Sep 30, 2021 | -7.26% |
| Jun 30, 2021 | -34.46% |
| Mar 31, 2021 | -20.98% |